Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01OBM
|
|||
| Former ID |
DIB013077
|
|||
| Drug Name |
MEDl-559
|
|||
| Indication | Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 1/2 | [1] | |
| Company |
Astrazeneca; medimmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00767416) A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.